Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose IV Vitamin C + VLCD in Terminal Colon Cancer
NCT04035096Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in colon cancer, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
ascorbic acid
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT04035096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04035096.